<a href="https://laohu8.com/S/APVO">Aptevo Therapeutics Inc.</a> Enters Standby Equity Purchase Agreement for Up to $25 Million in Common Stock Sales with Yorkville
On June 16, 2025, Aptevo Therapeutics Inc. entered into a Standby Equity Purchase Agreement with YA II PN, LTD. (Yorkville), allowing them the right to issue and sell up to $25 million of common stock over 36 months. The shares can be purchased by Yorkville at a price equal to 96% of the lowest daily VWAP during a three-day period, subject to certain conditions. The maximum number of shares that can be sold is capped at 151,755 unless certain conditions are met. No specific transaction details or number of shares sold are provided in the document.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-087368), on June 17, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。